Allscripts Introduces New App Expo to Showcase a Broader Range of Integrated Solutions

AllscriptsAllscripts (NASDAQ: MDRX) announced today that its Application Store has been relaunched as the Allscripts App Expo The rebrand will ensure Allscripts clients have an engaging way to identify all applications that have been built and certified through the Allscripts Developer Program (ADP) using Allscripts proprietary and FHIR APIs, in addition to select third party solutions sold by Allscripts. Previously, only certain partner applications were searchable and featured on the company’s Application Store. With this expansion, Allscripts will provide the opportunity for all active developers with a certified solution to showcase their solutions online via the App Expo.

Allscripts, one of the world's largest Health IT companies, first exposed APIs for third party connectivity in 2007 and launched a full developer program to support interoperability with Allscripts solutions and the industry's first online application store in 2010. The company's developer program enables developers to connect with multiple Allscripts electronic health records (EHR) and practice management solutions. Allscripts supports integration with on-premise, data-center-hosted and cloud-hosted environments across all specialties and for all sizes of physician offices and hospital organizations. Today there are hundreds of certified apps and devices available for Allscripts clients to choose from, with new certified solutions frequently added to the site.

"Over the past few years, we have seen an unprecedented increase in funding for health technology start-ups, with more organizations than ever looking to connect with Allscripts solutions via FHIR, our proprietary APIs and the other connectivity options we support through our Developer Program. Our program has continued to grow and expand to support this activity and foster innovation in our industry," said Tina Joros, Vice President and General Manager of Allscripts. "The new App Expo is just the latest step toward making it easier for our clients to find solutions that will continue to help them improve their technology ecosystem and accomplish their practice and health system goals."

On March 8 at 10 a.m. ET, Tina Joros will participate in a panel discussion during ViVE 2022 in Miami, FL, titled "Setting the Future on FHIR or Setting FHIR on Fire." The panelists will discuss the continuum of data-sharing in healthcare, the ever-evolving world of interoperability and more. The Allscripts App Expo will also be on display in the Allscripts booth at ViVE (#450) at the annual Health Information Management Systems Society (HIMSS) conference March 15-17 in Orlando, FL in booth 1279. You can visit the new site at https://expo.allscripts.com and search by keyword, Allscripts products or categories.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Most Popular Now

Open Call HORIZON-JU-IHI-2022-03-05: Dig…

Mental health disorders represent an area of severe unmet public health need. This has been further negatively impacted by the COVID-19 pandemic, with a substantial increase in the number and...

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Brain Area Necessary for Fluid Intellige…

A team led by UCL and UCLH researchers have mapped the parts of the brain that support our ability to solve problems without prior experience - otherwise known as fluid...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...